<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02539771</url>
  </required_header>
  <id_info>
    <org_study_id>P111121</org_study_id>
    <nct_id>NCT02539771</nct_id>
  </id_info>
  <brief_title>Sleep Study in Adult Patients With Major Sickle Cell Disease With Paroxysmal Nocturnal Events</brief_title>
  <acronym>DREPASOM</acronym>
  <official_title>Sleep Study in Adult Patients With Major Sickle Cell Disease With Paroxysmal Nocturnal Events</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hypothesis is that the occurrence of nocturnal Vaso-Occlusive Crisis (VOC) and priapism in
      adults might be related to episodes of nocturnal desaturation secondary to a sleep apnea
      syndrome. Investigator hypothesize that chronic biological consequences of Obstructive Sleep
      Apnea (hypercoagulability, endothelial dysfunction ...) favour VOC and acute manifestations
      (nocturnal desaturation) favour nocturnal VOC.

      The confirmation of this hypothesis will lead investigator to propose a systematic screening
      of obstructive sleep apnea (OSA) in patients with nocturnal VOC. Moreover, systematic
      treatment of OSA in sickle cell patients could help significantly reduce the number and
      severity of nocturnal VOC.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2014</start_date>
  <completion_date type="Anticipated">September 2018</completion_date>
  <primary_completion_date type="Anticipated">September 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of patients with nocturnal desaturation and patients with OSA</measure>
    <time_frame>at 1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Oxygen desaturation index</measure>
    <time_frame>at 1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Minimum oxygen saturation level</measure>
    <time_frame>at 1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quantitative analysis of biomarkers in plasma samples</measure>
    <time_frame>at 1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quantitative analysis of proinflammatory and anti-inflammatory cytokines</measure>
    <time_frame>at 1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Minimum oxygen saturation level during rapid eye movement (REM) sleep in patients with recurrent priapism and in patients who never presented priapism</measure>
    <time_frame>at 1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Apnea-Hypopnea Index</measure>
    <time_frame>at 1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleep time with arterial oxygen saturation less than 90%</measure>
    <time_frame>at 1 year</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Sickle Cell Disease</condition>
  <arm_group>
    <arm_group_label>Nocturnal VOC</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Diurnal VOC</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Slightly symptomatic</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Polysomnography and blood sample</intervention_name>
    <description>Blood collection is a specific intervention of protocol for the 3 arms. Polysomnography is a specific intervention for the arms &quot; Diurnal VOC &quot; and &quot; Slightly symptomatic &quot;</description>
    <arm_group_label>Nocturnal VOC</arm_group_label>
    <arm_group_label>Diurnal VOC</arm_group_label>
    <arm_group_label>Slightly symptomatic</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Night VOC Group:

          -  night VOC ≥ 2 in the previous year

          -  written informed consent

        Daytime VOC Group:

          -  VOC no nocturnal

          -  diurnal VOC ≥ 2 in the previous year

          -  written informed consent

        Slightly symptomatic group:

          -  no hospitalization for VOC

          -  written informed consent

        Exclusion Criteria:

          -  Taking opioids

          -  Taking medication that alters sleep (antidepressants, benzodiazepines ...)

          -  Known history of sleep apnea syndrome

          -  Known history of serious psychiatric disorder

          -  Recent vaso-occlusive crisis (within 3 weeks)

          -  Changes in background treatment (Hydrea or exchange transfusions) in the past 12
             months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anoosha Habibi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - Hôpitaux de Paris</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Serge Adnot, MD. PhD</last_name>
    <phone>(0)1 49 81 26 90</phone>
    <phone_ext>+33</phone_ext>
    <email>serge.adnot@inserm.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Anoosha Habibi, MD</last_name>
    <phone>(0)1 49 81 27 73</phone>
    <phone_ext>+33</phone_ext>
    <email>anoosha.habibi@hmn.aphp.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Henri Mondor Hospital</name>
      <address>
        <city>Creteil</city>
        <zip>94010</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anoosha Habibi, MD</last_name>
      <phone>(0)1 49 81 27 73</phone>
      <phone_ext>+33</phone_ext>
      <email>anoosha.habibi@hmn.aphp.fr</email>
    </contact>
    <contact_backup>
      <last_name>Serge Adnot, MD. PhD</last_name>
      <phone>(0)1 49 81 26 90</phone>
      <phone_ext>+33</phone_ext>
      <email>serge.adnot@inserm.fr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 27, 2015</study_first_submitted>
  <study_first_submitted_qc>August 31, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 3, 2015</study_first_posted>
  <last_update_submitted>June 19, 2017</last_update_submitted>
  <last_update_submitted_qc>June 19, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 20, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>vaso-occlusive crisis</keyword>
  <keyword>obstructive sleep apnea</keyword>
  <keyword>priapism</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anemia, Sickle Cell</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

